1. Office of National Drug Control Policy, Synthetic Drugs (a.k.a. K2, Spice, Bath Salts, etc.) 〈http://www.whitehouse.gov/ondcp/ondcp-fact-sheets/synthetic-drugs-k2-spice-bath-salts〉, (accessed 7.10.16)
2. D.M. Bush, D.A. Woodwell, Substance Abuse and Mental Health Services Administration, The CBHSQ report: Update: drug-related emergency department visits involving synthetic cannabinoids 〈http://www.samhsa.gov/data/sites/default/files/SR-1378/SR-1378.pdf〉 (accessed 21.9.16)
3. European Monitoring Centre for Drugs and Drug Addiction, European drug report 2016: trends and developments, Publications Office of the European Union, Luxembourg 〈http://www.emcdda.europa.eu/system/files/publications/2637/TDAT16001ENN.pdf〉, 2016 (accessed 20.5.16)
4. The challenge of synthetic drugs in East and South-East Asia and Oceania: trends and patterns of amphetamine-type stimulants and new psychoactive substances, A report from the global SMART programme, United Nations Office on Drugs and Crime 〈http://www.unodc.org/documents/southeastasiaandpacific/Publications/2015/drugs/ATS_2015_Report_web.pdf〉, May 2015 (accessed 20.5.16)
5. H. Williams, Synthetic marijuana, other designer drugs enter United States – legally, CBS News, cbsnews.com 〈http://www.cbsnews.com/news/synthetic-marijuana-other-designer-drugs-enter-united-states-legally/〉, 4.12.13 (accessed 19.5.16)